Spots Global Cancer Trial Database for metastatic lung neuroendocrine neoplasm

Every month we try and update this database with for metastatic lung neuroendocrine neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors	NCT02589522	Metastatic Lung... Metastatic Lung... Metastatic Lung... Metastatic Mali... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Berzosertib Quality-of-Life... Therapeutic Con... Whole-Brain Rad...	18 Years -	National Cancer Institute (NCI)
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors	NCT04665739	Advanced Lung N... Functioning Lun... Locally Advance... Lung Neuroendoc... Lung Neuroendoc... Lung Neuroendoc... Metastatic Lung... Metastatic Lung... Non-Functioning... Recurrent Lung ... Unresectable Lu... Unresectable Lu...	Biospecimen Col... Computed Tomogr... Everolimus Fludeoxyglucose... Lutetium Lu 177... Positron Emissi... Single Photon E...	18 Years -	National Cancer Institute (NCI)
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	NCT03375320	Carcinoid Tumor Functioning Pan... Intermediate Gr... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Low Grade Lung ... Lung Neuroendoc... Lung Neuroendoc... Metastatic Dige... Metastatic Dige... Metastatic Lung... Metastatic Lung... Metastatic Panc... Metastatic Panc... Metastatic Thym... Neuroendocrine ... Neuroendocrine ... Non-Functioning... Pancreatic Sero... Thymic Neuroend... Unresectable Di... Unresectable Di... Unresectable Lu... Unresectable Pa... Unresectable Th...	Cabozantinib S-... Computed Tomogr... Magnetic Resona... Placebo Adminis... Quality-of-Life... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors	NCT02589522	Metastatic Lung... Metastatic Lung... Metastatic Lung... Metastatic Mali... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Berzosertib Quality-of-Life... Therapeutic Con... Whole-Brain Rad...	18 Years -	National Cancer Institute (NCI)
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors	NCT02589522	Metastatic Lung... Metastatic Lung... Metastatic Lung... Metastatic Mali... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Berzosertib Quality-of-Life... Therapeutic Con... Whole-Brain Rad...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: